Browsing by Author "Nasr, Mohamed"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    COVID-19 SAFETY PRECAUTIONS
    (MSA, 2022) Farid, Ahmed; Nasr, Mohamed
    In this paper, we show the impact of covid-19 on millions of people and how people have suffered from it in a variety of ways, so we provide a compatible system for covid-19 safety precautions consisting of multiple methods of detection split into access control parts such as temperature detection, facemask detection and those both methods are responsible for entrance , while the monitoring part based on social distancing, and also face mask detection, both of those parts using developed algorithms based on developed concepts, As a result, those techniques of detection are utilized for early identification to limit the chance of covid-19 infection, or any type of flu, including fever symptoms.
  • Thumbnail Image
    Item
    Pimitespib, an HSP90 inhibitor, augments nifuroxazide-induced disruption in the IL-6/STAT3/HIF-1α autocrine loop in rats with bleomycin-challenged lungs: Evolutionary perspective in managing pulmonary fibrosis
    (Elsevier Masson s.r.l., 2022-07-27) El-Kashef, Dalia H; Youssef, Mahmoud E; Nasr, Mohamed; Alrouji, Mohammed; Alhajlah, Sharif; AlOmeirf, Othman; El Adle Khalaf, Noura; Abdel Ghaffar, Dalia M; Jamil, Lubna; Abdel-Nasser, Zeinab M; Ibrahim, Samar; Abdeldaiem, Mahmoud Said Ibrahim; Donia, Sally S; Mohammed, Osama A; Morsy, Nesreen Elsayed; Shata, Ahmed; Saber, Sameh
    Idiopathic pulmonary fibrosis is a fatal lung disorder in which the etiology and pathogenesis are still unobvious. Effective treatments are urgently needed considering that lung transplantation is the only treatment that could improve outcomes. This study aimed to investigate the therapeutic significance of the dual administration of pimitespib, an HSP90 inhibitor, and nifuroxazide, a STAT3 inhibitor, against bleomycin-induced pulmonary